ArticleScientific reports2025
Abnormality prediction and forecasting of laboratory values from electrocardiogram signals using multimodal deep learning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the feasibility of using electrocardiogram (ECG) data combined with basic patient metadata to estimate and monitor prompt laboratory abnormalities. We use the MIMIC-IV dataset to train multimodal deep learning models on ECG waveforms, demographics, biometrics, and vital signs. Our model is a structured state space classifier with late fusion for metadata. We frame the task as individual binary classifications per abnormality and evaluate performance using AUROC. The models achieve strong performance, with AUROCs above 0.70 for 24 lab values in abnormality prediction and up to 24 in abnormality forecasting, across cardiac, renal, hematological, metabolic, immunological, and coagulation categories. NTproBNP (≥ 353 pg/mL) is best predicted (AUROC > 0.90). Other values with AUROC > 0.85 include Hemoglobin (≥ 17.5 g/dL), Albumin (≥ 5.2 g/dL), and Hematocrit (≥ 51%). Our findings show ECG combined with clinical data enables prompt abnormality prediction and forecasting of lab abnormalities, offering a non-invasive, cost-effective alternative to traditional testing. This can support early intervention and enhanced patient monitoring. ECG and clinical data can help estimate and monitor abnormal lab values, potentially improving care while reducing reliance on invasive and costly procedures.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.